Prof. Jonathan B. Angel

University of Ottawa, Canada

Email: [email protected]

Qualifications

1988  M.D., University of Toronto School of Medicine

1984  B.Sc., University of Toronto, University College

Publications (selected)

1. Razmi, M., Almasi, Y., Larrivée, M., et al. (2026). Killer-cell immunoglobulin-like receptors define a potent effector program in human γδTcells. JCI Insight, 11(11), Article e201160.
2. Nicholds, J., Dans, M., & Angel, JB. (2025). Awareness of organ donation among people living with HIV in Canada: a cross-sectional study. HIV Research & Clinical Practice, 26(1), Article 2555114.
3. Molyer, B., Ameeriar, Y., & Angel, JB. (2025). SMAC mimetics sensitize HIV-infected cells to oncolytic virus-mediated death. Frontiers in Immunology, 16, Article 1665811.
4. Margolese, S., Reinhard, R., Masching, R., et al. (2025). Reflections upon a life well-lived: A tribute to Ron Rosenes. Journal of Virus Eradication, 11(2), Article 100599.
5. Giguère, P., Agtarap, K., McGuinty, M., et al. (2025). Bictegravir/emtricitabine/tenofovir alafenamide after virologic failure to cabotegravir/rilpivirine. AIDS, 39(6), 777-779.
6. Ford, S. L., Felizarta, F., Han, K. L., et al. (2025). Thigh Injections of Cabotegravir plus Rilpivirine in Virally Suppressed Adults With Human Immunodeficiency Virus Type 1: A Substudy of the Phase 3b ATLAS-2M Study. Clinical Infectious Diseases, 81(1), 101-112.
7. Barros, P. O., Schinkel, S. C. B., Nayak, A. L., et al. (2025). Failure of γδ T Cell Recovery in the Gut With Effective Anti-HIV Therapy. Journal of Immunology Research, 2025(1), Article 9883892.
8. Miller, C., Giguère, P., Mcguinty, M., & Angel, JB. (2024). Breakthrough HIV viraemia on bictegravir/emtricitabine/tenofovir alafenamide in the third trimester of pregnancy. Journal of Antimicrobial Chemotherapy, 79(9), 2390-2391.
9. Costiniuk, C. T., Lee, T., Singer, J., et al. (2024). Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study. Vaccines, 12(5), Article 447.
10. Vulesevic, B., Lauscher, D., Kumar, D., et al. (2024). Policies and practice of solid organ donation amongst people living with HIV in Canada: time for education and re-evaluation. HIV Research & Clinical Practice, 25(1), Article 2323848.
11. Schinkel, S. C. B., Barros, P. O., Berthoud, T., et al. (2024). Comparative analysis of human gut- and blood-derived mononuclear cells: contrasts in function and phenotype. Frontiers in Immunology, 15, Article 1336480.
12. Angel, J. B., Freilich, J., Arthurs, E., et al. (2023). Adherence to oral antiretroviral therapy in Canada, 2010-2020. AIDS, 37(13), 2031-2040.
13. Costiniuk, C. T., Singer, J., Lee, T. R. Y., et al. (2023). Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada. AIDS, 37(12), F25-F35.
14. Dufour, C., Ruiz, M. J., Pagliuzza, A., et al. (2023). Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ART. Cell Reports, 42(9), Article 113053.
15. Swaminathan, S., Scorza, T., Yero, A., et al. (2023). Impact of in vitro HIV infection on human thymic regulatory T cell differentiation. Frontiers in Microbiology, 14, Article 1217801.
16. Cowan, J., Pakhale, S., & Angel, JB. (2023). Mulching pneumonitis in a patient with chronic granulomatosis. Canadian Medical Association Journal, 195(6), E249-E250.
17. Alexandrova, Y., Yero, A., Bouassa, R. S. M., et al. (2023). SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study). Viruses-Basel, 15(2), Article 575.
18. Costiniuk, C. T., Singer, J., Lee, T., et al. (2023). COVID-19 vaccine immunogenicity in people with HIV. AIDS, 37(1), F1-F10.
19. Karver, T. S., Pascual-Bernaldez, M., Berni, A., et al. (2023). Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial. AIDS Patient Care and STDs, 37(1), 53-59.
20. Lessard, D., Lebouché, B., Morneau, A., et al. (2023). Donating One's Body to HIV Cure Research Through Canadian Medical Assistance in Dying: A Case Study. Current HIV Research, 21(4), 264-267.

Profile Details

https://www.uottawa.ca/faculty-medicine/directory/dr-jonathan-angel
https://ohri.ca/en/find-researcher/jonathanangel
https://www.researchgate.net/scientific-contributions/Jonathan-B-Angel-2161203009

WOS ResearcherID: GCT-5256-2022